Article Versions Notes

Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit L-o, Sangchang P, Senawong T. Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models. Pharmaceuticals. 2025; 18(7):960. https://doi.org/10.3390/ph18070960

Namwan, Narissara, Gulsiri Senawong, Chanokbhorn Phaosiri, Pakit Kumboonma, La-or Somsakeesit, Pitchakorn Sangchang, and Thanaset Senawong. 2025. "Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models" Pharmaceuticals 18, no. 7: 960. https://doi.org/10.3390/ph18070960

Namwan, N., Senawong, G., Phaosiri, C., Kumboonma, P., Somsakeesit, L.-o., Sangchang, P., & Senawong, T. (2025). Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models. Pharmaceuticals, 18(7), 960. https://doi.org/10.3390/ph18070960